Nov 04, 2019
Boehringer Ingelheim and Lilly modernise alliance to focus full expertise on Jardiance®
Oct 18, 2019
IOF: A Fracture Every 3 Seconds Worldwide - That's Osteoporosis
Oct 15, 2019
AACE Joins IOF in Support of World Osteoporosis Day 2019
Oct 14, 2019
Abbott and Omada Health Partner to Offer Integrated Digital Health and Coaching Experience for People with Type 2 Diabetes
Sep 11, 2019
New Report on Burden of Osteoporosis Highlights Huge and Growing Economic and Human Toll of the Disease
Sep 10, 2019
New global survey highlights impact of diabetes management on family members
Aug 30, 2019
Mitotane Market is Expected to Grow With a CAGR of ~ 5% in the Forecast Period - PMR
Aug 12, 2019
DarioHealth® Clinical Study Data Shows the Dario Membership Program Assists Diabetes Patients in Achieving Pre-Diabetic Blood-Glucose Levels and Consistent In-Range Measurements
Jul 24, 2019
BAQSIMI(TM) (glucagon) Nasal Powder 3 mg, the First and Only Nasally Administered Glucagon to Treat Severe Hypoglycemia in Adults and Children with Diabetes Ages Four Years and Older, Approved by FDA
Jun 27, 2019
The National Osteoporosis Foundation Launches a First-of-its-Kind Tool to Collect Patient Input for the Osteoporosis Field
Jun 11, 2019
DarioHealth Reports Improvement in Glycemic Outcomes With Key Diabetes Findings at the American Diabetes Association's 79th Scientific Sessions
Jun 10, 2019
Detailed findings from CAROLINA® outcome trial support long-term cardiovascular safety profile of Tradjenta®
Jun 10, 2019
Sihuan's Abstracts regarding Clinical Trial Progress of SGLT-2 Inhibitor Selected for Poster Presentation at the American Diabetes Association's Scientific Sessions
Jun 09, 2019
Type 1 Diabetes May Affect Brain Development, Beginning in Early Childhood
Jun 08, 2019
Researchers Find Accelerating Rates of Severe Complications in Young Adults with Youth-Onset Type 2 Diabetes
Jun 08, 2019
New Recommendations for Time-in-Range Targets During Continuous Glucose Monitoring Presented Today at the ADA's Scientific Sessions
Jun 08, 2019
Pilot Study Shows That Investigational Interconnected Diabetes Management Solution From Ascensia Significantly Reduced HbA1c in People With Type 2 Diabetes
Jun 08, 2019
New Data Show Use of Abbott's FreeStyle® Libre System Significantly Reduces HbA1c Levels in People Living with Type 2 Diabetes
Jun 04, 2019
U.S. FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes
May 16, 2019
Leading Clinical Conference on Bone Health Taking Place in La Jolla, California from May 15-18